Transcripts

Altimmune (ALT) earnings call transcripts

Earnings call transcripts for Altimmune, Inc., with a summary, the guidance given, and what analysts pressed on.

Open ALT in Gloom →
Altimmune's chart, financials and news, free in your browser.Open ALT in Gloom →
  • Q2 2026 earnings call

    Management framed the quarter as rapid execution toward a liver-focused franchise, with AUD data expanding pemvidutide’s strategic and commercial potential.

    Aug 12, 2026Confident0.82